Skip to main content
Clinical Trials/NL-OMON49680
NL-OMON49680WithdrawnPhase 4

Bronchodilators for wheeze in young children presenting to primary care: a randomised, placebo-controlled, multicentre, parallel group trial. - KIds WIth wheeze trial (KIWI)

niversitair Medisch Centrum Utrecht0 sites150 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Withdrawn
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
2 to 11 (—)

Inclusion Criteria

  • -children aged 6-24 months
  • - wheezing as confirmed by clinical examination (chest auscultation)
  • - a score of 7 or higher on a parent-reported respiratory symptom score.

Exclusion Criteria

  • - prematurity
  • - major congenital malformations
  • - pre-existing pulmonary disease as diagnosed by a paediatrician
  • - continuous use of inhalation medication
  • - physician visit because of wheezing in previous two weeks
  • - or use of asthma medication in the previous two weeks
  • - wheezing as a result of upper airway obstruction (i.e. laryngitis
  • subglottica/pseudocroup)
  • - severe illness requiring inhalation medication, prescription of antibiotics,
  • or hospital referral; during the consultation of inclusion.

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials